Stay updated on Nivolumab-Ixazomib Combo in MM: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab-Ixazomib Combo in MM: Clinical Trial page.

Latest updates to the Nivolumab-Ixazomib Combo in MM: Clinical Trial page
- Check5 days agoChange DetectedA new revision (v3.4.3) was added and the previous revision (v3.4.2) was deleted in the study record history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added to the history, and a government funding notice and the v3.4.1 revision were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check41 days agoChange DetectedAdded a government-operation notice banner and the latest site revision tag (Revision: v3.4.1); the previous revision (v3.4.0) was removed.SummaryDifference0.8%

- Check48 days agoChange DetectedThe history page UI was updated to include a new revision label (v3.4.0) and added guidance on how color-coded additions and deletions are displayed; no substantive study data or results were modified.SummaryDifference1%

- Check62 days agoChange DetectedThe page's Record History shows a new revision entry (v3.3.4) replacing the previous (v3.3.3), which is a metadata update; no substantive study data or content changes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedThe history shows a new revision entry (v3.3.3) added and older items (HHS Vulnerability Disclosure and Revision: v3.3.2) removed, which are minor site maintenance updates in the footer and do not alter trial information or study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivolumab-Ixazomib Combo in MM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ixazomib Combo in MM: Clinical Trial page.